Form 4: UnitedHealth Group Director Kristen Gil Reports Planned Acquisition of Dividend Equivalent Shares Under 10b5-1 Plan

UnitedHealth Group Inc. Director Kristen Gil reported a planned acquisition of 7 shares of common stock as dividend equivalents on vested deferred stock units, scheduled for June 24, 2025, under a Rule 10b5-1 plan.

Summary

• Kristen Gil, a Director at UnitedHealth Group Inc. (UNH), reported a planned transaction under a Rule 10b5-1 plan.
• The transaction, scheduled for June 24, 2025, involves the acquisition of 7 shares of Common Stock.
• These shares are acquired at a price of $0, representing dividend equivalents paid on vested deferred stock units.
• The dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.
• Following this transaction, Kristen Gil will directly own 1,558 shares of Common Stock.
• Additionally, 3,800 shares are indirectly owned by a Trust.

Sentiment

Score: 7

Explanation: The filing indicates a routine insider transaction related to compensation, specifically dividend equivalents, which is a positive sign of continued director ownership and alignment with shareholder interests. There are no negative implications.

Positives

• Acquisition of additional shares by a director, indicating continued alignment of interests with shareholders.
• Shares acquired are dividend equivalents, suggesting the company is paying dividends on deferred stock units, a common form of executive compensation.
• The transaction is part of a Rule 10b5-1 plan, indicating a pre-scheduled and transparent insider trading arrangement.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook, as it is a report of a planned insider transaction.

Management Comments

• The filing indicates that the shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units.

Industry Context

This Form 4 filing is a routine disclosure of a planned insider transaction and does not provide broader industry context. It reflects a director's compensation structure, which is common across various industries for aligning executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director aligns their interests with those of shareholders, potentially signaling confidence in the company's long-term performance.

Key Dates

Keywords

UnitedHealth Group, UNH, SEC Form 4, Insider Transaction, Director Stock Acquisition, Dividend Equivalents, Deferred Stock Units, Rule 10b5-1 Plan, Kristen Gil